Literature DB >> 19821271

Psychological treatments for bulimia nervosa and binging.

Phillipa Pj Hay1, Josué Bacaltchuk, Sergio Stefano, Priyanka Kashyap.   

Abstract

BACKGROUND: A specific manual-based form of cognitive behavioural therapy (CBT) has been developed for the treatment of bulimia nervosa (CBT-BN) and other common related syndromes such as binge eating disorder. Other psychotherapies and modifications of CBT are also used.
OBJECTIVES: To evaluate the efficacy of CBT, CBT-BN and other psychotherapies in the treatment of adults with bulimia nervosa or related syndromes of recurrent binge eating. SEARCH STRATEGY: Handsearch of The International Journal of Eating Disorders since first issue; database searches of MEDLINE, EXTRAMED, EMBASE, PsycInfo, CURRENT CONTENTS, LILACS, SCISEARCH, CENTRAL and the The Cochrane Collaboration Depression, Anxiety & Neurosis Controlled Trials Register; citation list searching and personal approaches to authors were used. Search date June 2007. SELECTION CRITERIA: Randomised controlled trials of psychotherapy for adults with bulimia nervosa, binge eating disorder and/or eating disorder not otherwise specified (EDNOS) of a bulimic type which applied a standardised outcome methodology and had less than 50% drop-out rate. DATA COLLECTION AND ANALYSIS: Data were analysed using the Review Manager software program. Relative risks were calculated for binary outcome data. Standardised mean differences were calculated for continuous variable outcome data. A random effects model was applied. MAIN
RESULTS: 48 studies (n = 3054 participants) were included. The review supported the efficacy of CBT and particularly CBT-BN in the treatment of people with bulimia nervosa and also (but less strongly due to the small number of trials) related eating disorder syndromes.Other psychotherapies were also efficacious, particularly interpersonal psychotherapy in the longer-term. Self-help approaches that used highly structured CBT treatment manuals were promising. Exposure and Response Prevention did not enhance the efficacy of CBT.Psychotherapy alone is unlikely to reduce or change body weight in people with bulimia nervosa or similar eating disorders. AUTHORS'
CONCLUSIONS: There is a small body of evidence for the efficacy of CBT in bulimia nervosa and similar syndromes, but the quality of trials is very variable and sample sizes are often small. More and larger trials are needed, particularly for binge eating disorder and other EDNOS syndromes. There is a need to develop more efficacious therapies for those with both a weight and an eating disorder.

Entities:  

Mesh:

Year:  2009        PMID: 19821271      PMCID: PMC7034415          DOI: 10.1002/14651858.CD000562.pub3

Source DB:  PubMed          Journal:  Cochrane Database Syst Rev        ISSN: 1361-6137


  170 in total

1.  Cognitive-behavioral therapy for bulimia nervosa: time course and mechanisms of change.

Authors:  G Terence Wilson; Christopher C Fairburn; W Stewart Agras; B Timothy Walsh; Helena Kraemer
Journal:  J Consult Clin Psychol       Date:  2002-04

2.  Intensive nutritional counselling in bulimia nervosa: a role for supplementation with fluoxetine?

Authors:  P J Beumont; J D Russell; S W Touyz; C Buckley; K Lowinger; P Talbot; G F Johnson
Journal:  Aust N Z J Psychiatry       Date:  1997-08       Impact factor: 5.744

3.  A comparison of nutritional management with stress management in the treatment of bulimia nervosa.

Authors:  R G Laessle; P J Beumont; P Butow; W Lennerts; M O'Connor; K M Pirke; S W Touyz; S Waadt
Journal:  Br J Psychiatry       Date:  1991-08       Impact factor: 9.319

4.  A randomized controlled trial of fluoxetine and cognitive behavioral therapy for bulimia nervosa: short-term outcome.

Authors:  D S Goldbloom; M Olmsted; R Davis; J Clewes; M Heinmaa; W Rockert; B Shaw
Journal:  Behav Res Ther       Date:  1997-09

5.  A comparison study of antidepressants and structured intensive group psychotherapy in the treatment of bulimia nervosa.

Authors:  J E Mitchell; R L Pyle; E D Eckert; D Hatsukami; C Pomeroy; R Zimmerman
Journal:  Arch Gen Psychiatry       Date:  1990-02

6.  Cue reactivity as a predictor of outcome with bulimia nervosa.

Authors:  Frances A Carter; Cynthia M Bulik; Virginia V McIntosh; Peter R Joyce
Journal:  Int J Eat Disord       Date:  2002-04       Impact factor: 4.861

7.  The relative efficacy of fluoxetine and manual-based self-help in the treatment of outpatients with bulimia nervosa.

Authors:  J E Mitchell; L Fletcher; K Hanson; M P Mussell; H Seim; R Crosby; M Al-Banna
Journal:  J Clin Psychopharmacol       Date:  2001-06       Impact factor: 3.153

8.  A placebo-controlled study of fluoxetine in continued treatment of bulimia nervosa after successful acute fluoxetine treatment.

Authors:  Steven J Romano; Katherine A Halmi; Neena P Sarkar; Stephanie C Koke; Julia S Lee
Journal:  Am J Psychiatry       Date:  2002-01       Impact factor: 18.112

9.  The validity of the DSM-IV scheme for classifying bulimic eating disorders.

Authors:  P Hay; C Fairburn
Journal:  Int J Eat Disord       Date:  1998-01       Impact factor: 4.861

10.  A comparison of sequenced individual and group psychotherapy for patients with bulimia nervosa.

Authors:  Lauri Nevonen; Anders G Broberg
Journal:  Int J Eat Disord       Date:  2006-03       Impact factor: 4.861

View more
  40 in total

Review 1.  Considerations on self-psychology and eating disorders.

Authors:  GianCarlo Di Luzio
Journal:  Eat Weight Disord       Date:  2015-09-16       Impact factor: 4.652

2.  Predictors and moderators of treatment outcome in a randomized clinical trial for adults with symptoms of bulimia nervosa.

Authors:  Erin C Accurso; Stephen A Wonderlich; Ross D Crosby; Tracey L Smith; Marjorie H Klein; James E Mitchell; Scott J Crow; Kelly C Berg; Carol B Peterson
Journal:  J Consult Clin Psychol       Date:  2015-12-21

3.  Long-term efficacy of psychological treatments for binge eating disorder.

Authors:  Anja Hilbert; Monica E Bishop; Richard I Stein; Marian Tanofsky-Kraff; Anne K Swenson; R Robinson Welch; Denise E Wilfley
Journal:  Br J Psychiatry       Date:  2012-01-26       Impact factor: 9.319

Review 4.  Pharmacological and psychosocial management of mental, neurological and substance use disorders in low- and middle-income countries: issues and current strategies.

Authors:  Jair de Jesus Mari; Luís Fernando Tófoli; Cristiano Noto; Li M Li; Alessandra Diehl; Angélica M Claudino; Mario F Juruena
Journal:  Drugs       Date:  2013-09       Impact factor: 9.546

Review 5.  [Treatment of bulimia nervosa].

Authors:  H Salbach-Andrae; E Pfeiffer
Journal:  Nervenarzt       Date:  2011-09       Impact factor: 1.214

6.  Association between objective and subjective binge eating and psychopathology during a psychological treatment trial for bulimic symptoms.

Authors:  Andrea B Goldschmidt; Erin C Accurso; Ross D Crosby; Li Cao; Jo Ellison; Tracey L Smith; Marjorie H Klein; James E Mitchell; Scott J Crow; Stephen A Wonderlich; Carol B Peterson
Journal:  Appetite       Date:  2016-08-20       Impact factor: 3.868

7.  Associations between physical activity and eating-disorder psychopathology among individuals categorised with binge-eating disorder and bulimia nervosa.

Authors:  Stephanie G Kerrigan; Janet A Lydecker; Carlos M Grilo
Journal:  Int J Clin Pract       Date:  2019-09-11       Impact factor: 2.503

8.  The Efficacy of Cognitive Behavioral Therapy: A Review of Meta-analyses.

Authors:  Stefan G Hofmann; Anu Asnaani; Imke J J Vonk; Alice T Sawyer; Angela Fang
Journal:  Cognit Ther Res       Date:  2012-07-31

9.  Stepped care and cognitive-behavioural therapy for bulimia nervosa: randomised trial.

Authors:  James E Mitchell; Stewart Agras; Scott Crow; Katherine Halmi; Christopher G Fairburn; Susan Bryson; Helena Kraemer
Journal:  Br J Psychiatry       Date:  2011-03-17       Impact factor: 9.319

Review 10.  Binge-Eating Disorder in Adults: A Systematic Review and Meta-analysis.

Authors:  Kimberly A Brownley; Nancy D Berkman; Christine M Peat; Kathleen N Lohr; Katherine E Cullen; Carla M Bann; Cynthia M Bulik
Journal:  Ann Intern Med       Date:  2016-06-28       Impact factor: 25.391

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.